High expression of CRLF2 may work in conjunction with IKZF1 deletion to drive oncogenesis of ALL and both of them have significance in an integrated prognostic model for adult high-risk ALL. The gene discussed is CRLF2; the disease is acute lymphoblastic leukemia.